EMA Authorised: Zometa (zoledronic acid;zoledronic acid monohydrate) — Phoenix Labs Unlimited Company

View source ↗

Summary

The EMA has authorised Zometa (zoledronic acid) for cancer and bone-related indications, with Phoenix Labs Unlimited Company as the marketing authorization hold…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Cancer
• Hypercalcemia of Malignancy
• Osteoporosis

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Status: Authorised. Therapeutic area: Cancer;Fractures, Bone. MAH: Phoenix Labs Unlimited Company. Decision date: 05/09/2024